LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
96447-8
|
WE CARE Survey
|
-
|
Pt
|
^Caregiver
|
-
|
WE CARE
|
PANEL.SURVEY.GNHLTH
| 4 |
WE CARE Survey [WE CARE] Caregiver
| null | null |
ACTIVE
|
2.70
|
2.7
|
96448-6
|
SARS coronavirus 2 N gene
|
PrThr
|
Pt
|
Saliva
|
Ord
|
Probe.amp.tar.CDC primer-probe set N1
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N1
|
SARS-CoV-2 N gene Sal Ql NAA N1
| null |
ACTIVE
|
2.69
|
2.69
|
96449-4
|
Cell growth
|
PrThr
|
Pt
|
Tumor
|
Ord
|
Tissue culture
|
SPEC
| 1 |
Cell growth [Presence] of Tumor in Tissue culture
|
Cell growth Tumor Ql Tiss culture
| null |
ACTIVE
|
2.69
|
2.69
|
96450-2
|
Hepatocellular carcinoma risk
|
Score
|
Pt
|
^Patient
|
Qn
|
GALAD
|
CHEM
| 1 |
Hepatotocellular carcinoma risk [Score] GALAD
|
GALAD Score
| null |
ACTIVE
|
2.69
|
2.7
|
96451-0
|
Alpha-1-Fetoprotein & Alpha-1-Fetoprotein.L3 panel
|
-
|
Pt
|
Ser/Plas
|
-
| null |
PANEL.CHEM
| 1 |
Alpha-1-Fetoprotein and Alpha-1-Fetoprotein.L3 panel - Serum or Plasma
|
AFP+AFP.L3 Pnl SerPl
| null |
ACTIVE
|
2.69
|
2.69
|
96452-8
|
Hepatocellular carcinoma risk panel
|
-
|
Pt
|
Ser/Plas
|
-
| null |
PANEL.CHEM
| 1 |
Hepatocellular carcinoma risk panel - Serum or Plasma
|
Hep Ca Risk Pnl SerPl
| null |
ACTIVE
|
2.69
|
2.69
|
9645-3
|
Metanephrine/Creatinine
|
MRto
|
Pt
|
Urine
|
Qn
| null |
CHEM
| 1 |
Metanephrine/Creatinine [Mass Ratio] in Urine
|
Metaneph/Creat Ur
| null |
ACTIVE
|
1.0i
|
2.73
|
96453-6
|
Coagulation factor XI activity & inhibitor panel
|
-
|
Pt
|
PPP
|
-
|
Coag
|
PANEL.COAG
| 1 |
Coagulation factor XI activity and inhibitor panel - Platelet poor plasma by Coagulation assay
|
Fact XI Act + Inhib Pnl PPP
| null |
ACTIVE
|
2.69
|
2.69
|
96454-4
|
Coagulation factor II inhibitor
|
PrThr
|
Pt
|
PPP
|
Ord
|
Coag
|
COAG
| 1 |
Coagulation factor II inhibitor [Presence] in Platelet poor plasma by Coagulation assay
|
Fact II Inhib PPP Ql
| null |
ACTIVE
|
2.69
|
2.69
|
96455-1
|
Coagulation factor II activity & inhibitor panel
|
-
|
Pt
|
PPP
|
-
|
Coag
|
PANEL.COAG
| 1 |
Coagulation factor II activity and inhibitor panel - Platelet poor plasma by Coagulation assay
|
Fact II Act + Inhib Pnl PPP
| null |
ACTIVE
|
2.69
|
2.69
|
96456-9
|
Coagulation factor VIII activity & inhibitor panel
|
-
|
Pt
|
PPP
|
-
|
Coag
|
PANEL.COAG
| 1 |
Coagulation factor VIII activity and inhibitor panel - Platelet poor plasma by Coagulation assay
|
Fact VIII Act + Inhib Pnl PPP
| null |
ACTIVE
|
2.69
|
2.69
|
96457-7
|
Coagulation factor X activity & inhibitor panel
|
-
|
Pt
|
PPP
|
-
|
Coag
|
PANEL.COAG
| 1 |
Coagulation factor X activity and inhibitor panel - Platelet poor plasma by Coagulation assay
|
Fact X Act + Inhib Pnl PPP
| null |
ACTIVE
|
2.69
|
2.69
|
96458-5
|
Coagulation factor V activity & inhibitor panel
|
-
|
Pt
|
PPP
|
-
|
Coag
|
PANEL.COAG
| 1 |
Coagulation factor V activity and inhibitor panel - Platelet poor plasma by Coagulation assay
|
Fact V Act + Inhib Pnl PPP
| null |
ACTIVE
|
2.69
|
2.69
|
96459-3
|
Coagulation factor IX activity & inhibitor panel
|
-
|
Pt
|
PPP
|
-
|
Coag
|
PANEL.COAG
| 1 |
Coagulation factor IX activity and inhibitor panel - Platelet poor plasma by Coagulation assay
|
Fact IX Act + Inhib Pnl PPP
| null |
ACTIVE
|
2.69
|
2.69
|
96460-1
|
Thyroglobulin^post thyroglobulin antibody neutralization
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
CHEM
| 1 |
Thyroglobulin [Mass/volume] in Serum or Plasma by Immunoassay --post thyroglobulin antibody neutralization
|
Thyrogl p thyrogl Ab neut SerPl IA-mCnc
| null |
ACTIVE
|
2.69
|
2.69
|
9646-1
|
Sulfide
|
MCnc
|
Pt
|
Bld
|
Qn
| null |
DRUG/TOX
| 1 |
Sulfide [Mass/volume] in Blood
|
Sulfide Bld-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
96461-9
|
Gastrin releasing polypeptide prohormone
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
CHEM
| 1 |
Gastrin releasing polypeptide prohormone [Mass/volume] in Serum or Plasma by Immunoassay
|
ProGRP SerPl IA-mCnc
| null |
ACTIVE
|
2.69
|
2.69
|
96462-7
|
Sirolimus
|
SCnc
|
Pt
|
Bld
|
Qn
|
IA
|
DRUG/TOX
| 1 |
Sirolimus [Moles/volume] in Blood by Immunoassay
|
Sirolimus Bld IA-sCnc
| null |
ACTIVE
|
2.69
|
2.69
|
96463-5
|
Copper.free/Copper.total
|
MFr
|
Pt
|
Ser/Plas
|
Qn
|
Calculated
|
DRUG/TOX
| 1 |
Copper free/Total copper in Serum or Plasma by calculation
|
Copper free/Total copper MFr SerPl Calc
| null |
ACTIVE
|
2.69
|
2.69
|
96464-3
|
Inositol 1,4,5-trisphosphate receptor type 1 Ab.IgG
|
PrThr
|
Pt
|
Ser
|
Ord
|
IF
|
SERO
| 1 |
Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Presence] in Serum by Immunofluorescence
|
IP3R 1 IgG Ser Ql IF
| null |
ACTIVE
|
2.69
|
2.69
|
96465-0
|
Inositol 1,4,5-trisphosphate receptor type 1 Ab.IgG
|
Titr
|
Pt
|
Ser
|
Qn
|
IF
|
SERO
| 1 |
Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Titer] in Serum by Immunofluorescence
|
IP3R 1 IgG Titr Ser IF
| null |
ACTIVE
|
2.69
|
2.69
|
96466-8
|
Inositol 1,4,5-trisphosphate receptor type 1 Ab.IgG
|
PrThr
|
Pt
|
Ser
|
Ord
|
CBA IFA
|
SERO
| 1 |
Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
|
IP3R 1 IgG Ser Ql CBA IFA
| null |
ACTIVE
|
2.69
|
2.69
|
96467-6
|
Inositol 1,4,5-trisphosphate receptor type 1 Ab.IgG
|
PrThr
|
Pt
|
CSF
|
Ord
|
IF
|
SERO
| 1 |
Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
|
IP3R 1 IgG CSF Ql IF
| null |
ACTIVE
|
2.69
|
2.69
|
96468-4
|
Inositol 1,4,5-trisphosphate receptor type 1 Ab.IgG
|
PrThr
|
Pt
|
CSF
|
Ord
|
CBA IFA
|
SERO
| 1 |
Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
|
IP3R 1 IgG CSF Ql CBA IFA
| null |
ACTIVE
|
2.69
|
2.69
|
96469-2
|
Inositol 1,4,5-trisphosphate receptor type 1 Ab.IgG
|
Titr
|
Pt
|
CSF
|
Qn
|
IF
|
SERO
| 1 |
Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
|
IP3R 1 IgG Titr CSF IF
| null |
ACTIVE
|
2.69
|
2.69
|
964-7
|
C super little x Ag
|
PrThr
|
Pt
|
RBC^BPU
|
Ord
| null |
BLDBK
| 1 |
C sup(x) Ag [Presence] on Red Blood Cells from Blood product unit
|
C sup(x) Ag RBC BPU Ql
| null |
ACTIVE
|
1.0
|
2.73
|
96470-0
|
Rho GTPase-activating protein 26 Ab.IgG
|
Titr
|
Pt
|
Ser
|
Qn
|
IF
|
SERO
| 1 |
Rho GTPase-activating protein 26 IgG Ab [Titer] in Serum by Immunofluorescence
|
GRAF IgG Titr Ser IF
| null |
ACTIVE
|
2.69
|
2.69
|
96471-8
|
Rho GTPase-activating protein 26 Ab.IgG
|
PrThr
|
Pt
|
Ser
|
Ord
|
IF
|
SERO
| 1 |
Rho GTPase-activating protein 26 IgG Ab [Presence] in Serum by Immunofluorescence
|
GRAF IgG Ser Ql IF
| null |
ACTIVE
|
2.69
|
2.69
|
96472-6
|
Rho GTPase-activating protein 26 Ab.IgG
|
PrThr
|
Pt
|
Ser
|
Ord
|
CBA IFA
|
SERO
| 1 |
Rho GTPase-activating protein 26 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
|
GRAF IgG Ser Ql CBA IFA
| null |
ACTIVE
|
2.69
|
2.69
|
96473-4
|
Rho GTPase-activating protein 26 Ab.IgG
|
PrThr
|
Pt
|
CSF
|
Ord
|
IF
|
SERO
| 1 |
Rho GTPase-activating protein 26 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
|
GRAF IgG CSF Ql IF
| null |
ACTIVE
|
2.69
|
2.69
|
96474-2
|
Rho GTPase-activating protein 26 Ab.IgG
|
Titr
|
Pt
|
CSF
|
Qn
|
IF
|
SERO
| 1 |
Rho GTPase-activating protein 26 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
|
GRAF IgG Titr CSF IF
| null |
ACTIVE
|
2.69
|
2.69
|
96475-9
|
Rho GTPase-activating protein 26 Ab.IgG
|
PrThr
|
Pt
|
CSF
|
Ord
|
CBA IFA
|
SERO
| 1 |
Rho GTPase-activating protein 26 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
|
GRAF IgG CSF Ql CBA IFA
| null |
ACTIVE
|
2.69
|
2.69
|
96476-7
|
IgLON family member 5 Ab.IgG
|
PrThr
|
Pt
|
Ser
|
Ord
|
IF
|
SERO
| 1 |
IgLON5 IgG Ab [Presence] in Serum by Immunofluorescence
|
IgLON5 IgG Ser Ql IF
| null |
ACTIVE
|
2.69
|
2.69
|
96477-5
|
IgLON family member 5 Ab.IgG
|
Titr
|
Pt
|
Ser
|
Qn
|
IF
|
SERO
| 1 |
IgLON5 IgG Ab [Titer] in Serum by Immunofluorescence
|
IgLON5 IgG Titr Ser IF
| null |
ACTIVE
|
2.69
|
2.69
|
96478-3
|
IgLON family member 5 Ab.IgG
|
PrThr
|
Pt
|
Ser
|
Ord
|
CBA IFA
|
SERO
| 1 |
IgLON5 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
|
IgLON5 IgG Ser Ql CBA IFA
| null |
ACTIVE
|
2.69
|
2.69
|
9647-9
|
Thiosulfate
|
MCnc
|
Pt
|
Bld
|
Qn
| null |
CHEM
| 1 |
Thiosulfate [Mass/volume] in Blood
|
Thiosulfate Bld-mCnc
| null |
ACTIVE
|
1.0i
|
2.73
|
96479-1
|
IgLON family member 5 Ab.IgG
|
PrThr
|
Pt
|
CSF
|
Ord
|
IF
|
SERO
| 1 |
IgLON5 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
|
IgLON5 IgG CSF Ql IF
| null |
ACTIVE
|
2.69
|
2.69
|
96480-9
|
IgLON family member 5 Ab.IgG
|
Titr
|
Pt
|
CSF
|
Qn
|
IF
|
SERO
| 1 |
IgLON5 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
|
IgLON5 IgG Titr CSF IF
| null |
ACTIVE
|
2.69
|
2.69
|
96481-7
|
IgLON family member 5 Ab.IgG
|
PrThr
|
Pt
|
CSF
|
Ord
|
CBA IFA
|
SERO
| 1 |
IgLON5 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
|
IgLON5 IgG CSF Ql CBA IFA
| null |
ACTIVE
|
2.69
|
2.69
|
96482-5
|
Alpha-internexin Ab.IgG
|
PrThr
|
Pt
|
CSF
|
Ord
|
CBA IFA
|
SERO
| 1 |
Alpha-internexin IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
|
Alpha-internexin IgG CSF Ql CBA IFA
| null |
ACTIVE
|
2.69
|
2.69
|
96483-3
|
Alpha-internexin Ab.IgG
|
PrThr
|
Pt
|
Ser
|
Ord
|
CBA IFA
|
SERO
| 1 |
Alpha-internexin IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
|
Alpha-internexin IgG Ser Ql CBA IFA
| null |
ACTIVE
|
2.69
|
2.69
|
96484-1
|
Neuronal intermediate filament heavy chain Ab.IgG
|
PrThr
|
Pt
|
Ser
|
Ord
|
CBA IFA
|
SERO
| 1 |
Neuronal intermediate filament heavy chain IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
|
NIF-H IgG Ser Ql CBA IFA
| null |
ACTIVE
|
2.69
|
2.69
|
96485-8
|
Neuronal intermediate filament light chain Ab.IgG
|
PrThr
|
Pt
|
Ser
|
Ord
|
CBA IFA
|
SERO
| 1 |
Neuronal intermediate filament light chain IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
|
NIF-L IgG Ser Ql CBA IFA
| null |
ACTIVE
|
2.69
|
2.69
|
96486-6
|
Neuronal intermediate filament Ab.IgG
|
PrThr
|
Pt
|
Ser
|
Ord
|
IF
|
SERO
| 1 |
Neuronal intermediate filament IgG Ab [Presence] in Serum by Immunofluorescence
|
NIF IgG Ser Ql IF
| null |
ACTIVE
|
2.69
|
2.69
|
9648-7
|
Chlorothiazide
|
MCnc
|
Pt
|
Urine
|
Qn
| null |
DRUG/TOX
| 1 |
Chlorothiazide [Mass/volume] in Urine
|
Chlorothiazide Ur-mCnc
| null |
ACTIVE
|
1.0i
|
2.73
|
96487-4
|
Neuronal intermediate filament Ab.IgG
|
Titr
|
Pt
|
Ser
|
Qn
|
IF
|
SERO
| 1 |
Neuronal intermediate filament IgG Ab [Titer] in Serum by Immunofluorescence
|
NIF IgG Titr Ser IF
| null |
ACTIVE
|
2.69
|
2.69
|
96488-2
|
Neuronal intermediate filament heavy chain Ab.IgG
|
PrThr
|
Pt
|
CSF
|
Ord
|
CBA IFA
|
SERO
| 1 |
Neuronal intermediate filament heavy chain IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
|
NIF-H IgG CSF Ql CBA IFA
| null |
ACTIVE
|
2.69
|
2.69
|
96489-0
|
Neuronal intermediate filament light chain Ab.IgG
|
PrThr
|
Pt
|
CSF
|
Ord
|
CBA IFA
|
SERO
| 1 |
Neuronal intermediate filament light chain IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
|
NIF-L IgG CSF Ql CBA IFA
| null |
ACTIVE
|
2.69
|
2.69
|
96490-8
|
Neuronal intermediate filament Ab.IgG
|
PrThr
|
Pt
|
CSF
|
Ord
|
IF
|
SERO
| 1 |
Neuronal intermediate filament IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
|
NIF IgG CSF Ql IF
| null |
ACTIVE
|
2.69
|
2.69
|
96491-6
|
Neuronal intermediate filament Ab.IgG
|
Titr
|
Pt
|
CSF
|
Qn
|
IF
|
SERO
| 1 |
Neuronal intermediate filament IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
|
NIF IgG Titr CSF IF
| null |
ACTIVE
|
2.69
|
2.69
|
96492-4
|
Cells.CD3+CD8+CD27+CD45RO+CD62L+
|
NCnc
|
Pt
|
Bld
|
Qn
| null |
CELLMARK
| 1 |
CD3+CD8+CD27+CD45RO+CD62L+ cells [#/volume] in Blood
|
CD3+CD8+CD27+CD45RO+CD62L+ cells # Bld
| null |
ACTIVE
|
2.69
|
2.69
|
96493-2
|
T-cell naive & memory & activated subsets panel
|
-
|
Pt
|
Bld
|
Qn
| null |
PANEL.CELLMARK
| 1 |
T-cell naive and memory and activated subsets panel - Blood
|
T-cell naive + mem + act subsets Pnl Bld
| null |
ACTIVE
|
2.69
|
2.69
|
96494-0
|
ABL1 & ABL2 & PDGFRB gene rearrangements
|
Find
|
Pt
|
Bld/Tiss
|
Doc
|
FISH
|
MOLPATH.REARRANGE
| 1 |
ABL1 and ABL2 and PDGFRB gene rearrangements in Blood or Tissue by FISH
|
ABL1 + ABL2 + PDGFRB rearr Bld/T FISH
| null |
ACTIVE
|
2.69
|
2.69
|
9649-5
|
Hydroflumethiazide
|
MCnc
|
Pt
|
Urine
|
Qn
| null |
DRUG/TOX
| 1 |
Hydroflumethiazide [Mass/volume] in Urine
|
Hydroflumethiazide Ur-mCnc
| null |
ACTIVE
|
1.0i
|
2.73
|
96495-7
|
ABL2 gene rearrangements
|
Find
|
Pt
|
Bld/Tiss
|
Doc
|
FISH
|
MOLPATH.REARRANGE
| 1 |
ABL2 gene rearrangements in Blood or Tissue by FISH
|
ABL2 rearrange Bld/T FISH
| null |
ACTIVE
|
2.69
|
2.69
|
96496-5
|
Glycine receptor alpha-1 subunit Ab.IgG
|
PrThr
|
Pt
|
Ser
|
Ord
|
CBA IFA
|
SERO
| 1 |
Glycine receptor alpha-1 subunit IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
|
GlyRa-1 IgG Ser Ql CBA IFA
| null |
ACTIVE
|
2.69
|
2.69
|
96497-3
|
Glycine receptor alpha-1 subunit Ab.IgG
|
PrThr
|
Pt
|
CSF
|
Ord
|
CBA IFA
|
SERO
| 1 |
Glycine receptor alpha-1 subunit IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
|
GlyRa-1 IgG CSF Ql CBA IFA
| null |
ACTIVE
|
2.69
|
2.69
|
96498-1
|
La Crosse virus Ab.IgG & IgM panel
|
-
|
Pt
|
CSF
|
-
| null |
PANEL.MICRO
| 1 |
La Crosse virus Ab.IgG and IgM panel - Cerebral spinal fluid
|
LACV Ab.IgG & IgM panel CSF
| null |
ACTIVE
|
2.69
|
2.69
|
96499-9
|
La Crosse virus Ab.IgG & IgM panel
|
-
|
Pt
|
Ser
|
-
| null |
PANEL.MICRO
| 1 |
La Crosse virus Ab.IgG and IgM panel - Serum
|
LACV Ab.IgG & IgM panel Ser
| null |
ACTIVE
|
2.69
|
2.69
|
96500-4
|
Hyperoxaluria panel
|
-
|
Pt
|
Ser/Plas
|
-
| null |
PANEL.CHEM
| 1 |
Hyperoxaluria panel - Serum or Plasma
|
Hyperoxaluria Pnl SerPl
| null |
ACTIVE
|
2.69
|
2.69
|
96501-2
|
TIF1-gamma Ab
|
ACnc
|
Pt
|
Ser
|
Qn
|
IA
|
SERO
| 1 |
TIF1-gamma Ab [Units/volume] in Serum by Immunoassay
|
TIF1-gamma Ab Ser IA-aCnc
| null |
ACTIVE
|
2.69
|
2.69
|
96502-0
|
Number of wheelchair pushes
|
NRat
|
XXX
|
^Patient
|
Qn
| null |
H&P.HX
| 2 |
Number of wheelchair pushes per time period
|
# wheelchair push nRate
| null |
ACTIVE
|
2.69
|
2.69
|
9650-3
|
Methyclothiazide
|
MCnc
|
Pt
|
Urine
|
Qn
| null |
DRUG/TOX
| 1 |
Methyclothiazide [Mass/volume] in Urine
|
Methyclothiazide Ur-mCnc
| null |
ACTIVE
|
1.0i
|
2.73
|
96503-8
|
Adenovirus DNA
|
PrThr
|
Pt
|
Respiratory
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
Adenovirus DNA [Presence] in Respiratory specimen by NAA with probe detection
|
HAdV DNA Resp Ql NAA+probe
| null |
ACTIVE
|
2.69
|
2.69
|
96504-6
|
Protein/Osmolality
|
Ratio
|
Pt
|
Urine
|
Qn
| null |
CHEM
| 1 |
Protein/Osmolality [Ratio] in Urine
|
Prot/Osmolality Ur-Rto
| null |
ACTIVE
|
2.69
|
2.69
|
96505-3
|
Colorado tick fever virus Ab.IgM
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Colorado tick fever virus IgM Ab [Presence] in Specimen by Immunoassay
|
CTFV IgM Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96506-1
|
Oropouche virus Ab.IgG
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Oropouche virus IgG Ab [Presence] in Specimen by Immunoassay
|
Oropouche virus IgG Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96507-9
|
California encephalitis virus Ab.IgG
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
California encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay
|
CEV IgG Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96508-7
|
Bunyamwera virus Ab.IgG
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Bunyamwera virus IgG Ab [Presence] in Specimen by Immunoassay
|
Bunyamwera virus IgG Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96509-5
|
Tick-borne encephalitis virus Ab.IgG
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Tick-borne encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay
|
TBEV IgG Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96510-3
|
Heartland banyangvirus Ab.IgG
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Heartland banyangvirus IgG Ab [Presence] in Specimen by Immunoassay
|
HRTV IgG Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
9651-1
|
metOLazone
|
MCnc
|
Pt
|
Urine
|
Qn
| null |
DRUG/TOX
| 1 |
metOLazone [Mass/volume] in Urine
|
metOLazone Ur-mCnc
| null |
ACTIVE
|
1.0i
|
2.73
|
96511-1
|
Bwamba virus Ab.IgG
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Bwamba virus IgG Ab [Presence] in Specimen by Immunoassay
|
Bwamba virus IgG Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96512-9
|
Rift Valley fever virus Ab.IgG
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Rift valley fever virus IgG Ab [Presence] in Specimen by Immunoassay
|
RVFV IgG Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96513-7
|
Sandfly fever Naples virus Ab.IgG
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Sandfly fever Naples virus IgG Ab [Presence] in Specimen by Immunoassay
|
SFNV IgG Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96514-5
|
Cache Valley virus Ab.IgM
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Cache valley virus IgM Ab [Presence] in Specimen by Immunoassay
|
CVV IgM Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96515-2
|
Sandfly fever Sicilian virus Ab.IgG
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Sandfly fever Sicilian virus IgG Ab [Presence] in Specimen by Immunoassay
|
SFSV IgG Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96516-0
|
Toscana virus Ab.IgG
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Toscana virus IgG Ab [Presence] in Specimen by Immunoassay
|
TOSV IgG Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96517-8
|
Bourbon virus Ab.IgG
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Bourbon virus IgG Ab [Presence] in Specimen by Immunoassay
|
Bourbon virus IgG Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96518-6
|
Onyong-nyong virus Ab.IgG
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Onyong-nyong virus IgG Ab [Presence] in Specimen by Immunoassay
|
ONN virus IgG Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96519-4
|
Semliki forest virus Ab.IgG
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Semliki Forest virus IgG Ab [Presence] in Specimen by Immunoassay
|
SFV IgG Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96520-2
|
Ilheus virus Ab.IgG
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Ilheus virus IgG Ab [Presence] in Specimen by Immunoassay
|
ILHV IgG Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96521-0
|
Cache Valley virus Ab.IgG
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Cache valley virus IgG Ab [Presence] in Specimen by Immunoassay
|
CVV IgG Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96522-8
|
Colorado tick fever virus Ab.IgG
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Colorado tick fever virus IgG Ab [Presence] in Specimen by Immunoassay
|
CTFV IgG Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96523-6
|
Ilheus virus Ab.IgM
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Ilheus virus IgM Ab [Presence] in Specimen by Immunoassay
|
ILHV IgM Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96524-4
|
Rocio virus Ab.IgM
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Rocio virus IgM Ab [Presence] in Specimen by Immunoassay
|
Rocio virus IgM Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96525-1
|
Semliki forest virus Ab.IgM
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Semliki Forest virus IgM Ab [Presence] in Specimen by Immunoassay
|
SFV IgM Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96526-9
|
Onyong-nyong virus Ab.IgM
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Onyong-nyong virus IgM Ab [Presence] in Specimen by Immunoassay
|
ONN virus IgM Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96527-7
|
Bourbon virus Ab.IgM
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Bourbon virus IgM Ab [Presence] in Specimen by Immunoassay
|
Bourbon virus IgM Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96528-5
|
Toscana virus Ab.IgM
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Toscana virus IgM Ab [Presence] in Specimen by Immunoassay
|
TOSV IgM Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
9652-9
|
N-desalkylflurazepam
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
DRUG/TOX
| 1 |
N-desalkylflurazepam [Mass/volume] in Serum or Plasma
|
Desalkylfluraz SerPl-mCnc
| null |
ACTIVE
|
1.0i
|
2.73
|
96529-3
|
Sandfly fever Sicilian virus Ab.IgM
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Sandfly fever Sicilian virus IgM Ab [Presence] in Specimen by Immunoassay
|
SFSV IgM Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96530-1
|
Sandfly fever Naples virus Ab.IgM
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Sandfly fever Naples virus IgM Ab [Presence] in Specimen by Immunoassay
|
SFNV IgM Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96531-9
|
Oropouche virus Ab.IgM
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Oropouche virus IgM Ab [Presence] in Specimen by Immunoassay
|
Oropouche virus IgM Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96532-7
|
Rift Valley fever virus Ab.IgM
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Rift valley fever virus IgM Ab [Presence] in Specimen by Immunoassay
|
RVFV IgM Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96533-5
|
Bwamba virus Ab.IgM
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Bwamba virus IgM Ab [Presence] in Specimen by Immunoassay
|
Bwamba virus IgM Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96534-3
|
Heartland banyangvirus Ab.IgM
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Heartland banyangvirus IgM Ab [Presence] in Specimen by Immunoassay
|
HRTV IgM Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96535-0
|
Tick-borne encephalitis virus Ab.IgM
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Tick-borne encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay
|
TBEV IgM Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
96536-8
|
Bunyamwera virus Ab.IgM
|
PrThr
|
Pt
|
XXX
|
Ord
|
IA
|
MICRO
| 1 |
Bunyamwera virus IgM Ab [Presence] in Specimen by Immunoassay
|
Bunyamwera virus IgM Spec Ql IA
| null |
ACTIVE
|
2.69
|
2.69
|
9653-7
|
Trichlormethiazide
|
MCnc
|
Pt
|
Urine
|
Qn
| null |
DRUG/TOX
| 1 |
Trichlormethiazide [Mass/volume] in Urine
|
TCM Ur-mCnc
| null |
ACTIVE
|
1.0i
|
2.73
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.